When COVID-19 Hits Tuberculosis: Unusual Association

Introduction: COVID-19 is a multi-organ disease secondary to SARS-Cov-2 this infection may be responsible in some cases for severe acute respiratory syndrome. The clinical characteristics and management of patients with pulmonary tuberculosis (TB). with are not yet clear and have not been sufficiently studied. Patient and method: In this observation, we report a case of SARS-Cov-2 infection revealing pulmonary tuberculosis, our management experience and the clinical and evolutionary data of this case. Results: This is a 20-year-old patient with pulmonary tuberculosis and COVID-19 co-infection held in front of an evocative clinical radio panel, positive COVID-19 PCR test and GeneXpert in sputum also positive. The thoracic CT showed an extended frosted glass appearance (25%-50%) with multiple parenchymal condensations in favor of a CORADS 5, with presence of multiple nodular opacities sometimes excavated. The patient is put on protocol: Hydroxychloroquine + Azithromycin sulfate, associated with antibacillary treatment. The clinical evolution was marked by apyrexia at the end of the 3rd day of treatment with progressive improvement of his respiratory symptomatology. Conclusion: With the rapid spread of the COVID-19 pandemic, broader studies are needed to study the prognosis of tuberculosis -COVID-19.